Clinical Trial Update: Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating carboplatin and paclitaxel with or without viral therapy in patients with recurrent or metastatic pancreatic cancer has completed, wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Acinar Cell Carcinoma
• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Viral therapy

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Pancreatic Acinar Cell Carcinoma, Pancreatic Ductal Adenocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2018-02-07